Literature DB >> 15680259

An investigation of binding sites for paracetamol in the mouse brain and spinal cord.

Lisa Godfrey1, Amanda Morselli, Peter Bennion, Geoffrey D Clarke, Susanna M O Hourani, Ian Kitchen.   

Abstract

Quantitative autoradiography has been used to assess whether [3H]paracetamol (3 microM) binds specifically to any area of the murine brain and spinal cord and to investigate whether paracetamol (1-100 microM) competes for binding to the nociceptin opioid peptide (NOP) receptor or to the nitrobenzylthioinosine (NBTI)-sensitive adenosine transporter in the brains of mice. [3H]paracetamol binding was homogenous and, although there was some indication of specific binding overall, this binding in most individual regions failed to reach statistical significance. However, thoracic segments of the spinal cord were found to have significantly higher specific binding than cervical and lumbar regions. Paracetamol did not significantly compete for binding to the NOP receptor or to the NBTI-sensitive adenosine transporter, showing that it does not mediate its effect via these sites. Although paracetamol did bind specifically to the murine brain and spinal cord, the binding was not region-specific, suggesting binding is not related to any particular neurotransmitter system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15680259     DOI: 10.1016/j.ejphar.2004.11.061

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  2 in total

1.  Effects of naloxone and flumazenil on antinociceptive action of acetaminophen in rats.

Authors:  Halit Madenoğlu; Mustafa Kaçmaz; Recep Aksu; Cihangir Bicer; Gülay Yaba; Karamehmet Yildiz; Kudret Doğru; Adem Boyaci
Journal:  Curr Ther Res Clin Exp       Date:  2010-04

Review 2.  Systematic Review of Systemic and Neuraxial Effects of Acetaminophen in Preclinical Models of Nociceptive Processing.

Authors:  Hiroshi Hoshijima; Matthew Hunt; Hiroshi Nagasaka; Tony Yaksh
Journal:  J Pain Res       Date:  2021-11-12       Impact factor: 3.133

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.